By David Liu
Sepember 12, 2007
WEDNESDAY September 12, 2007 (Foodconsumer.org) -- The Center for Science in the Public Interest (CSPI) today urged the government to halt what it called false statements on ads and labels for menopause supplement known as "Promensil".
A red-clover dietary supplement is being deceptively marketed to women for the relief of hot flashes, night sweats, and mood swings, the nonprofit organization alleged.
The CSPI said its own extensive analysis of studies on Promensil has found the supplement ineffective in relieving menopause symptoms in postmenopausal women.
The food policy watchdog urged the Food and Drug Administration and the Federal Trade Commission to crack down on the allegedly deceptive advertising and labeling of Promensil, which is sold by a California-based publicly traded company.
“Natrol’s ads for Promensil are some of the most dishonest we’ve seen for a dietary supplement in a while,” said CSPI senior nutritionist David Schardt. “It’s a shame that companies like this exploit the desire of women to find a safe, effective alternative to estrogen for the relief of their symptoms during menopause.”
The CSPI in its letter to the federal agencies ask that the company reimburse consumers who purchased the supplement, run corrective advertising to correct its prior claims and pay a fine.
Natrol has yet publicly responded to the CSPI allegations.
© Copyright 2004 - 2007
foodconsumer.org All rights
reserved
http://foodconsumer.org/7777/8888/C_hildren_amp_W_omen_33/091206162007_CSPI_finds_Promensil_ineffective_printer.shtml